Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14


Biomaterial arrays with defined adhesion ligand densities and matrix stiffness identify distinct phenotypes for tumorigenic and nontumorigenic human mesenchymal cell types.

Hansen TD, Koepsel JT, Le NN, Nguyen EH, Zorn S, Parlato M, Loveland SG, Schwartz MP, Murphy WL.

Biomater Sci. 2014 May;2(5):745-756.


A quantitative comparison of human HT-1080 fibrosarcoma cells and primary human dermal fibroblasts identifies a 3D migration mechanism with properties unique to the transformed phenotype.

Schwartz MP, Rogers RE, Singh SP, Lee JY, Loveland SG, Koepsel JT, Witze ES, Montanez-Sauri SI, Sung KE, Tokuda EY, Sharma Y, Everhart LM, Nguyen EH, Zaman MH, Beebe DJ, Ahn NG, Murphy WL, Anseth KS.

PLoS One. 2013 Dec 3;8(12):e81689. doi: 10.1371/journal.pone.0081689. eCollection 2013.


Detecting adverse events in surgery: comparing events detected by the Veterans Health Administration Surgical Quality Improvement Program and the Patient Safety Indicators.

Mull HJ, Borzecki AM, Loveland S, Hickson K, Chen Q, MacDonald S, Shin MH, Cevasco M, Itani KM, Rosen AK.

Am J Surg. 2014 Apr;207(4):584-95. doi: 10.1016/j.amjsurg.2013.08.031. Epub 2013 Nov 7.


A chemically-defined screening platform reveals behavioral similarities between primary human mesenchymal stem cells and endothelial cells.

Koepsel JT, Loveland SG, Schwartz MP, Zorn S, Belair DG, Le NN, Murphy WL.

Integr Biol (Camb). 2012 Dec;4(12):1508-21. doi: 10.1039/c2ib20029e.


Combinatorial screening of chemically defined human mesenchymal stem cell culture substrates.

Koepsel JT, Brown PT, Loveland SG, Li WJ, Murphy WL.

J Mater Chem. 2012;22(37):19474-19481.


Effects of resident duty hour reform on surgical and procedural patient safety indicators among hospitalized Veterans Health Administration and Medicare patients.

Rosen AK, Loveland SA, Romano PS, Itani KM, Silber JH, Even-Shoshan OO, Halenar MJ, Teng Y, Zhu J, Volpp KG.

Med Care. 2009 Jul;47(7):723-31. doi: 10.1097/MLR.0b013e31819a588f.


Validity of selected AHRQ patient safety indicators based on VA National Surgical Quality Improvement Program data.

Romano PS, Mull HJ, Rivard PE, Zhao S, Henderson WG, Loveland S, Tsilimingras D, Christiansen CL, Rosen AK.

Health Serv Res. 2009 Feb;44(1):182-204. doi: 10.1111/j.1475-6773.2008.00905.x. Epub 2008 Sep 17.


Use of VA and Medicare services by dually eligible veterans with psychiatric problems.

Carey K, Montez-Rath ME, Rosen AK, Christiansen CL, Loveland S, Ettner SL.

Health Serv Res. 2008 Aug;43(4):1164-83. doi: 10.1111/j.1475-6773.2008.00840.x. Epub 2008 Mar 17.


Performance of statistical models to predict mental health and substance abuse cost.

Montez-Rath M, Christiansen CL, Ettner SL, Loveland S, Rosen AK.

BMC Med Res Methodol. 2006 Oct 26;6:53.


Health status among 28,000 women veterans. The VA Women's Health Program Evaluation Project.

Frayne SM, Parker VA, Christiansen CL, Loveland S, Seaver MR, Kazis LE, Skinner KM.

J Gen Intern Med. 2006 Mar;21 Suppl 3:S40-6.


Case-mix adjusting performance measures in a veteran population: pharmacy- and diagnosis-based approaches.

Liu CF, Sales AE, Sharp ND, Fishman P, Sloan KL, Todd-Stenberg J, Nichol WP, Rosen AK, Loveland S.

Health Serv Res. 2003 Oct;38(5):1319-37.


Diagnostic cost groups (DCGs) and concurrent utilization among patients with substance abuse disorders.

Rosen AK, Loveland SA, Anderson JJ, Hankin CS, Breckenridge JN, Berlowitz DR.

Health Serv Res. 2002 Aug;37(4):1079-103.


Multiregional evaluation of the SimPlate heterotrophic plate count method compared to the standard plate count agar pour plate method in water.

Jackson RW, Osborne K, Barnes G, Jolliff C, Zamani D, Roll B, Stillings A, Herzog D, Cannon S, Loveland S.

Appl Environ Microbiol. 2000 Jan;66(1):453-4.


Evaluation of catheter placement in the treatment of venous air embolism.

Sink JD, Comer PB, James PM, Loveland SR.

Ann Surg. 1976 Jan;183(1):58-61.

Supplemental Content

Loading ...
Support Center